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Abstract: Proteases, also referred to as peptidases, are the enzymes that catalyse 
the hydrolysis of peptide bonds in polipeptides. A variety of biological functions 
and processes depend on their activity. Regardless of the organism’s complexity, 
peptidases are essential at every stage of life of every individual cell, since all 
protein molecules produced must be proteolytically processed and eventually 
recycled. Protease inhibitors play a crucial role in the required strict and 
multilevel control of the activity of proteases involved in processes conditioning 
both the physiological and pathophysiological functioning of an organism, as 
well as in host-pathogen interactions. This review describes the regulation of 
activity of bacterial proteases produced by dangerous human pathogens, 
focusing on the Staphylococcus genus.  
 
Key words: Protease, Protease inhibitor, Zymogen, Operon, Staphylococcus 
Unauthenticated
Download Date | 5/13/19 11:02 AM
CELLULAR & MOLECULAR BIOLOGY LETTERS 
 
213 
 
INTRODUCTION 
 
Proteases catalyse the cleavage of peptide bonds in proteins and peptides. 
Depending on the reaction they catalyse, proteases are divided into 
endopeptidases (also named proteinases), which preferentially hydrolyse peptide 
bonds in the inner regions of peptide chains, and exopeptidases, whose activity 
is directed at the amino- or carboxyl-termini of proteins. Based on their catalytic 
mechanism, proteases are divided into seven groups: aspartic acid proteases, 
cysteine proteases, glutamic acid proteases, metalloproteases, serine proteases, 
threonine proteases, and the seventh group, which constitutes a number of 
peptidases that cannot yet be assigned to any particular catalytic type. Among 
prokaryotic organisms, proteases of 6 of the catalytic types (except glutamic acid 
proteases) are common (for review see: [1]). In terms of enzyme specificity, the 
cleavage of peptide bonds by proteases may be specific, e.g. limited proteolysis, 
which depends on the amino acid sequence surrounding the hydrolysed site, or 
unspecific, which results in complete degradation of proteins to oligo-peptides 
and/or amino acids.  
 
 
 
Fig. 1. The levels of regulation of protease expression and activity. 
 
By cleaving peptide bonds, proteases may change the biological properties of 
polypeptide chains. Specific proteolysis often results in protein and peptide 
activation or inactivation, and unspecific proteolysis in their degradation, and 
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thus these enzymes are potentially dangerous for cells, and may alter their 
environment. Therefore, organisms have developed a wide range of mechanisms 
to control protease activity. This regulation may take place at any level of gene 
expression, from the clustering of protease genes in operons, through their 
modulation at the transcription and translation levels, to post-translational 
modifications and interactions with protease inhibitors and other proteins (see 
Fig. 1).  
 
The genetic organization of bacterial protease genes 
The extracellular proteases produced by various pathogens are often accessory 
proteins, not fundamental for cell growth and division, but considered virulence 
factors. These proteins are not produced constitutively, but regulated in response 
to various environmental and cellular stimuli. The genetic determinants for these 
virulence factors are frequently associated with mobile genetic elements such as 
plasmids, pathogenecity islands and integrated phages. Clustering of protease 
genes in larger transcriptional units (operons) allows their coordinated 
expression, which in turn may imply cooperation of the produced proteins.  
A good example of the diverse organization of genes is the genes coding for 
epidermolytic toxins from Staphylococcus aureus, the most virulent and 
important pathogen of the staphylococci. The genes for these proteins are spread 
all over the genome of the bacterium. The eta gene, encoding epidermolytic 
toxin A, is located in a prophage genome integrated in the S. aureus 
chromosome [2], while the etb gene, coding for epidermolytic toxin B, is located 
on a plasmid [3]. It was also shown by Yamaguchi et al. that the epidermolytic 
toxin D gene (etd) is placed tandemly in a DNA block together with the ADP-
ribosyltransferase gene (edin-B), forming a pathogenicity island on the 
chromosome [2].  
 
Fig. 2. The schematic genetic organization of Staphylococcus aureus proteases genes.  
Ssp (staphylococcal serine protease), spl (serine-like protease), etd (epidermolytic toxin D), 
and scp (staphylococcal cysteine protease) operons are spread all over the bacterial 
chromosome. The etb (epidermolytic toxin B) gene is located on the plasmid pETB. 
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Genes of other extracellular staphylococcal proteases are clustered in operons 
(see Fig. 2). In S. aureus, there is a tricistronic operon of staphylococcal serine 
protease (ssp) consisting of a gene (sspA) encoding glutamyl endopeptidase, also 
referred to as V8 protease, a gene (sspB) coding for cysteine protease, 
staphopain B, and a gene (sspC) for staphostatin B, a specific endogenous 
intracellular inhibitor of the latter protease [4-6]. The staphylococcal cysteine 
protease (scp) operon comprises a staphopain A gene (scpA) and a gene (scpB) 
coding for staphostatin A, an inhibitor of the protease [6-8]. The pathogenic 
strain S. aureus CH-91 produces a third cysteine protease with a high sequence 
homology to staphopain A [9, 10]. It was recently shown that a gene coding for 
the protease is clustered in a bicistronic operon together with a gene encoding  
a specific inhibitor of the protease [11]. A similar organization of the staphopain 
and staphostatin genes was also found in the genome of S. epidermidis [12], and 
in partially sequenced genomes of S. carnosus [13] and S. warneri [11]. In the 
case of the latter, genes coding for staphopain and staphostatin are preceded by  
a gene encoding an orthologue of the S. aureus serine protease. Moreover, in the 
majority of S. aureus strains, a unique operon (spl) coding for six serine 
protease-like proteins was identified. The encoded Spl proteins share 44 to 95% 
amino acid sequence identity with each other and 33 to 36% sequence identity 
with V8 protease. The spl operon is transcribed on a 5.5-kb transcript, but 
several non-random degradation products of this transcript were also identified 
[14]. Transcriptional coupling of protease and inhibitor genes is not limited to 
the Staphylococcus genus. In Pseudomonas aeruginosa, a major cause of 
nosocomial (hospital acquired) infections, the aprA gene, coding for an alkaline 
protease, is located in an operon together with aprI, encoding a specific inhibitor 
of this protease, and genes with products involved in the secretion of the 
protease [15]. Recently, a novel protease-inhibitor pair from Streptococcus 
pyogenes, an important human pathogen, was discovered [16]. However, 
contrary to staphostatins sharing a lipocalin-like fold [17], the inhibitor (Spi) 
encoded downstream of the streptopain (SpeB) gene possesses 70% sequence 
similarity to the SpeB propeptide [16].  
 
Transcriptional and translational control of protease expression 
Genes in operons are usually co-transcribed. However, the transcription process 
itself is dependent on a set of factors within the cell and/or its environment that 
regulate the initiation and intensity of the process. In S. aureus, the expression of 
extracellular proteases is controled at the transcription level by two main global 
regulatory systems: agr (accessory gene regulator) [18] and sar (staphylococcal 
accessory regulator) [19]. The agr locus is composed of two divergent 
transcriptional units, an operon agrBDCA under the control of the P2 promoter, 
and the P3 operon, which specifies a 0.5 kb transcript, RNA III. This last is the 
actual effector of the agr response, and, incidentally, encodes the agr-regulated 
peptide delta-hemolysin [20]. The action of the agr system is manifested at the 
end of the exponential phase of bacterial growth as a result of the accumulation 
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of an autoinducer peptide, encoded in agrD. As a consequence, surface-protein 
gene expression is repressed, and genes encoding secretory proteins, including 
proteases, are subsequently activated [21]. Gambello et al. described a similar 
two-component autoinducing system in P. aeroginosa, where both the 27-kDa 
LasR protein and pseudomonal autoinducer N-(3-oxododecanoyl)-L-homoserine 
lactone are necessary for efficient transcription of the aprA gene [22]. The LasR 
and the autoinducer form a complex, which subsequently binds to the DNA 
structure motif (“lux box”), and stimulates transcription of the protease gene 
among others [23]. 
In S. aureus, the sar locus codes for three copies of a transcription factor, SarA 
[24]. The factor may operate either indirectly, acting on promoters of the agr 
system [25], or directly regulate the transcription process of particular genes 
interacting with their promoters [26]. It was shown that SarA strongly inhibits 
the transcription of genes encoding extracellular proteases [8, 27]. Apart from 
the mentioned systems, other factors are also engaged in the regulation of 
protease gene transcription. The regulator Rot, which is claimed to be a SarA 
homologue, negatively controls the transcription of ssp and spl operons [28, 29]. 
Moreover, it was demonstrated that ssp, aur and scp transcription is repressed by 
σB, an alternative subunit of RNA polymerase [8, 30]. Hence, through the  
co-operation of the systems, the activity of different groups of genes, the 
products of which are indispensable in subsequent phases of bacterial growth 
and infection, is coordinated. Induction of extracellular protease expression in 
the beginning of the postexponential phase of growth in vitro is suspected to 
reflect the situation in vivo, in which the enzymes degrade host tissues supplying 
nutrients to the bacteria. Moreover, the proteases support the spread of the 
infection and dissemination of the bacteria into deeper tissue through the 
shedding of cell surface adhesion molecules and inactivation of the components 
of the host immune system [8].  
Clustering genes in operons allows for coordinated transcription. However, 
regulation of the expression intensity of the particular components of the operon 
is provided at the translation level, as a sequence disparity of the ribosome 
binding site (RBS). Such a situation is observed in the case of staphylococcal ssp 
and scp operons, where the RBS following a start codon for the staphostatin 
coding sequence diverges significantly from the TGGAGG(A/T) motif 
characteristic for RBS in gram-positive bacteria, including S. aureus. As a result, 
staphostatins, although indispensable for the bacteria, are produced in amounts 
at least a thousand times lower than staphopains, encoded in the same operon  
[6, 31].                
 
Post-translational modifications 
Many organisms, including bacteria, commonly utilize post-translational 
modifications to modulate the activity of the expressed proteins. Of the enzymes 
engaged in these processes, proteases play a significant role. For example, 
methionyl aminopeptidases remove a formylated methionine residue from newly 
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synthesized polypeptide chains (for review see: [32]), while signal peptidases 
cleave off signal sequences during protein translocation through the cytoplasmic 
membrane (for review see: [33]). In turn, proteases themselves are produced as 
inactive precursors, also referred to as zymogens. Subsequently, their activity is 
liberated by the post-translational removal of profragments of various lengths 
and locations in the precursor [34]. 
Several functions have been demonstrated for the propeptides during the 
processing of the protease precursors. The pro-sequence may be required for 
proper folding or to maintain the protease in an inactive form until its release 
from the cell, and for temporary docking of the molecule into the membrane. In 
some cases, propeptides have been shown to play multiple roles. The precursor 
for subtilisin, a serine endopeptidase produced by a variety of a Bacillus species, 
is a good example of a broad-function proenzyme. It is synthesized as  
a preproenzyme consisting of a typical signal peptide of 29 residues followed by 
a propeptide of 77 residues preceding the 275 residue segment of mature 
subtilisin [35]. First, the subtilisin propeptide restricts the proteolytic activity of 
the proenzyme. Second, it promotes the correct folding of the mature protease 
processes. Finally, it temporarily anchors the protein in the plasma membrane 
[36].  
Major staphylococcal extracellular proteases are produced as zymogens, 
followed by a signal sequence. The aureolysin precursor consists of 509 amino 
acids, of which (aa), the first 27 residues comprise a signal peptide removed 
during the secretion of the protein. Extracellularly, the 181 aa profragment is 
proteolytically detached, which results in the formation of a mature enzyme, 
constituting 301 aa [37]. The protease responsible for the removal of the 
profragment remains unknown. It was suggested that, similarly to other 
metalloproteases from the thermolysin family, the profragment is removed 
autocatalytically [38]. Recent studies, however, refute such a mechanism [8].  
V8 protease zymogen consists of a 29 aa signal peptide, a 39 aa profragment and 
an around 280 aa part comprising the enzymatically active part. The 
heterogeneity of the mature form arises from the variable number of three amino 
acid repeats (Pro-Asn/Asp-Asn) in the C-terminal part of the protein, which is  
a result of sspA gene polymorphism [39, 40]. Additional variation arises from 
autodigestion at the glutamic acid residue in the C-terminal part of the molecule 
[41]. The zymogen undergoes proteolytic activation via cleavage by aureolysin 
[42]; however, an alternative activation mechanism was also suggested, since in 
culture fluids of mutants deficient in metalloprotease, the mature form of  
V8 protease was also observed [8, 43]. Staphopain B (SspB) is expressed as  
a preproenzyme containing a 36 aa signal sequence. After extracellular release, 
V8 protease, encoded in the same operon, cleaves a 183 aa profragment which 
results in the formation of a mature, fully active protease [5]. However, contrary 
to the commonly accepted rule that profragments inhibit the proteolytic activity 
of zymogens, a slight enzymatic activity of prostaphopain B against a synthetic 
low molecular weight substrate was observed. Moreover, the lack of degradation 
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of the profragment by SspA and SspB suggest that the propeptide does not 
function as an inhibitor of that enzyme [5]. However, studies performed by 
Filipek et al. based on the structural and biochemical analysis of prostaphopain 
B contradict the above hypothesis [44]. It is of note that in the latter studies, the 
used zymogen differed slightly in the amino acid sequence of the profragment, 
which among other things, meant the affinity of the propeptide for the mature 
form of the protease was twice as high. However, both authors agree that 
activation of the zymogen is not autocatalytic, and that it goes through sequential 
events of limited proteolysis, where aureolysin activates V8 protease, which in 
turn releases an active staphopain B from its zymogen. The detailed mechanism 
of staphopain A post-translational activation remains unknown. One may 
suspect that the 25 aa signal peptide is removed during protein translocation 
through the cytoplasmic membrane. Recent studies showed that neither 
metalloprotease nor V8 protease and staphopain B are engaged in excising the 
189 aa profragment [8]. Similarly, in the case of staphopain A2, a homologue of 
staphopain A from the S. aureus CH-91 strain, the activation mechanism is 
obscure. Analysis of the encoding gene suggests that the protease is produced as 
a 399 aa preproenzyme. From the culture fluids, however, a 174 aa mature 
protease was isolated [9, 10]. The unusual method of post-translational 
activation was observed in a group of Spl proteases. They do not posses a typical 
profragment, only a 36 aa signal peptide [14]. This part of the molecule, 
however, is responsible for inhibiting the protease activity. The proteases are 
maintained latent until the signal peptide is removed by a signal peptidase.  
It was shown that additional, artificial amino acids at the N-terminal of the 
molecule are responsible for the lack of enzymatic activity of recombinant forms 
of the protease. Therefore, here the signal peptide fulfils a dual function, not 
only leading the protease through the cytoplasmic membrane but also preventing 
its proteolytic activity inside the cell [45]. 
S. pyogenes expresses an extracellular cysteine protease (SpeB) with a well-
documented role in pathogenesis (for review see: [46]; Tab. 1). The enzyme is 
produced as a zymogen where the prosegment inserts into the protease active 
site cleft and keeps the proenzyme inactive [47]. The activation occurs under 
reducing conditions by auto-proteolytic removal of the propeptide, resulting in 
the release of the 28-kDa mature form of the protease [48]. In several cases of 
metalloproteases from the thermolysin family, extracellular autoprocessing to 
the mature form of enzyme was also suggested. For instance, the 33-kDa 
elastase (LasB) from P. aeruginosa is initially synthesized as a 54-kDa 
preproenzyme with a typical 3-kDa N-terminal signal peptide, which is cleaved 
during its passage through the inner membrane. Then, in the periplasma, the  
18-kDa N-terminal propeptide is cut off by an autocatalytic mechanism and the 
mature elastase is released. The N-terminal propeptide forms a complex with 
mature elastase and protects the cell against intracellular proteolysis. Outside of 
the bacteria cell, the propeptide dissociates from the complex and is finally 
digested [49]. Vibro vulnificus, an emerging pathogen of humans which can 
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invade the bloodstream either through a wound or from the gastrointestinal tract, 
causing a severe and life-threatening illness called primary septicemia, produces 
a precursor of metalloprotease (VVP) that includes not only a signal peptide and 
an N-terminal propeptide, but also an additional C-terminal peptide. It was 
shown that the C-terminal propeptide is autocatalytically removed upon 
incubation at 37ºC. The additional C-terminal sequence is necessary for efficient 
attachment of the metalloprotease to protein substrates and the erythrocyte 
membrane [50].  
 
Tab. 1. Extracellular bacterial proteases and their roles in pathogenesis. 
 
Protease Catalytic class Organism Postulated role in pathogenesis References 
Aureolysin metal S. aureus 
Modulation of immunogenic reactions by 
affecting the stimulation of lymphocytes and 
inhibiting immunoglobulin production; 
deregulation of host proteolytic activity 
through inactivation of plasma serpins 
[51-53] 
Epidermolytic 
toxins serine S. aureus 
Cleavage of desmoglein 1; 
causative agents of staphylococcal scalded 
skin syndrome 
[54] 
 
Glutamylendo- 
peptidase  
(V8 protease) 
serine S. aureus 
Interference with the host defense 
mechanisms through inactivation of plasma 
serpins and degradation of immunoglobins 
[55] and ref. 
within 
Staphopains A 
and B cysteine S. aureus 
Tissue invasion and destruction associated 
with staphylococcal ulceration; sepsis 
development through liberation of kinins 
from kininogen 
[56, 57] 
Staphopain A2 cysteine S. aureus CH-91 Agent of atopic dermatitis in chickens [9] 
SplA - SplF serine S. aureus Unknown, but a high titer of anti-Spl antibodies correlates with edocarditis [58] 
Elastase (LasB) metal P. aeruginosa Laminin degradation leading to pseudomonal keratitis 
[59] and ref. 
within 
Alkaline 
protease (AprA) metal P. aeruginosa 
Laminin degradation leading to 
pseudomonal keratitis 
[59] and ref. 
within 
Streptopain 
(SpeB) cysteine S. pyogenes 
Host immune system and matrix protein 
degradation, liberation of interleukin-1 and 
kinins from their precursors leading to 
inflammation and severe streptococcal 
infections 
[46] and ref. 
within, [66] 
 
VVP metal V. vulnificus 
Vascular permeability enhancement; 
hemorrhagic tissue damage; causative factor 
for edematous skin lesions 
[38] and ref 
within 
56-kDa protease metal S. marcescens 
Degradation of defense-oriented humoral 
proteins and tissue constituents, leading to 
serratial pneumonia and keratitis 
[59] and ref. 
within 
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Interactions with inhibitors 
Proteolytic activation of zymogens is an irreversible process. This creates a need 
for additional mechanisms regulating post-translationally activated proteases. 
Modulation by specific inhibitors is the most common of these. However, in 
bacteria, endogenous proteins inhibiting the proteases are relatively rare. Higher 
organisms have developed various inhibitors of proteolytic enzymes, not only to 
control self-produced proteases. Protease inhibitors are also an important 
element of the host anti-pathogen defence system. Mammal defence protease 
inhibitors belong to two classes: the active-site inhibitors, represented by  
a superfamilies of serpins and cystatins; and the α2-macroglobulins. The 
members of the former group inactivate enzymes by binding to the active site, 
the latter act as molecular traps for the proteases. However, some bacteria have 
learned to utilize the inhibitors to regulate the activity of their extracellular 
proteases for their own purposes. 
Research on the mechanism of staphopain B maturation revealed the presence of 
a 109-amino acid inhibitor of the enzyme, encoded in one operon together with 
the mentioned protease [5]. Further papers report that the staphopain A operon 
also contains a similar inhibitor. The mentioned inhibitors were named 
staphostatins because of their extraordinary specificity to staphopains, and not to 
other papain superfamily members [6]. In vitro, staphostatins form tight 
noncovalent equimolar complexes with the target proteases, totally abolishing 
their peptidase activity. It was shown that a properly formed active site of the 
enzyme is not necessary for the binding since the proteolytically inactive 
mutants of staphopains still bind the inhibitor [6, 11]. Structural studies 
performed both with x-ray crystallography and NMR methods revealed that 
staphostatins are β-barrels formed by a three-stranded mixed β-sheet and a five-
stranded antiparallel β-sheet. Such a fold is closely related to lipocalins  
[7, 17, 60]. Further analysis shows that a loop composed of 5 amino acid 
residues (from 97 to 101), but particularly a 98-glycine residue adopting an 
unusual conformation which prevents G98-T99 peptide bond cleavage, is 
responsible for staphostatin inhibitory activity. This observation was confirmed 
by the construction of the G98 mutants. Since other amino acids cannot, for 
steric reasons, adopt the conformation taken by glycine, the molecules lost their 
inhibitory functions and were efficiently cleaved downstream of the mutated 
residue [61, 62]. It is worth noticing that staphostatins are localized 
intracellulary, whereas staphopains are secreted outside the cell. Therefore, the 
role of the former is in protection against autoproteolysis caused by misdirected 
staphopains which, instead of being secreted, remain inside the cell [6]. This 
suggestion was supported by both indirect and direct studies. The former 
evidence comes from the studies of the expression of staphopain A in 
Escherichia coli. The enzyme is toxic and may be produced only while 
coexpressed with its inhibitor staphostatin A [63]. Direct evidence was also 
presented by the construction of the staphostatin B knockout strain, which 
exhibits a wide range of striking pleiotropic alterations in its phenotype, 
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including a defect in growth [31]. It should also be noted that functional 
staphostatins were found in S. epidermidis, S. warneri and the pathogenic strain 
S. aureus CH-91 [11, 12]. This type of protection against secreted proteases 
prematurely activated in the cytoplasm is not limited to the Staphylococcus 
genus: recently, an intracellular inhibitor of cysteine protease from 
Streptococcus pyogenes was identified [16]. The inhibitor (Spi), unlike the 
staphostatins, is strikingly homologous in sequence to the SpeB propeptide, with 
37% residue identity and 70% sequence similarity. Thus, although Spi was also 
proposed to protect cytoplasmic proteins from the activity of SpeB, the inhibitor 
is likely to act in a manner similar to SpeB propeptide [16]. Although a lot is 
known about staphostatins and Spi inhibition of their target proteases, it remains 
unknown whether the process in vivo is reversible, or whether the prematurely 
activated proteases trapped in the complex with the inhibitors undergo 
degradation. 
The interaction of proteases with protease inhibitors does not always result in the 
inactivation of the former. Many peptidases, especially those produced by 
pathogenic microorganisms, are able to escape the inhibition, and moreover, 
efficiently degrade potential inhibitors. For example, staphylococcal 
extracellular proteases are able to cleave human blood serpins and kininogens, 
releasing kinins from the latter [52, 53, 57]. Streptococcal protease SpeB 
liberates bradykinin from human and mouse kininogens, instead of being 
inhibited. It is believed that it helps streptococci survive in sepsis and 
streptococcal toxic shock syndrome [64]. The only inhibitors capable of 
inhibiting proteases secreted by pathogens are α2-macroglobulins, which operate 
by the unique process of molecular entrapment. In this process, the protease, 
regardless its catalytic mechanism, is enclosed in the molecular cage of the  
α2-macroglobulin (α2M) polypeptide chain [65]. Protease entrapment disables 
the enzyme’s ability to hydrolyse macromolecular substrates too large to fit into 
the α2M cage, but leaves intact the ability of the entrapped enzyme to hydrolyse 
low molecular mass substrates small enough to enter the α2M cage and interact 
with the active site of the protease [66]. Protease entrapment is initiated by the 
proteolytic cleavage of a peptide bond in a specialized bait region of the α2M 
polypeptide, which triggers the molecular compaction that entraps the protease 
molecule [67]. Trapping of the protease by α2M results in complex structural 
changes on the surface of the inhibitor where the specific receptor recognition 
site is exposed. The protein complex is then delivered to a receptor-mediated 
endolytic system and degraded in secondary lysosomes. Receptors for α2M have 
also been found on fibroblasts and macrophages. Nevertheless, extracellular 
protease (56 kDa) from Serratia marcescens, a pathogen associated with urinary 
and respiratory tract infections, makes use of a semistable complex with α2M, 
which is internalised via receptors on fibroblasts, where the gradually 
regenerated active protease causes damage to the cells. Such a mechanism may 
also contribute to the cytotoxicity of Pseudomonas [68]. The unique properties 
of the inhibitor were probably utilized by S. pyogenes to regulate the activity of 
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its extracellular protease SpeB, and in turn its defence against antimicrobal 
peptides. Most strains of the bacteria express GRAB, an α2-macroglobulin-
binding cell wall-attached protein. SpeB is captured by the bound inhibitor and 
retained at the bacterial surface, where it efficiently degrades the antibacterial 
peptide LL-37 attacking the bacterial cell membrane [69].  
 
Other factors controlling the activity of proteases 
Under stress conditions, the stability of proteins is frequently upset. Misfolded or 
unfolded proteins appear. Therefore, among the factors involved in controlling 
the activity of proteases, a very important function is fulfilled by environmental 
factors like pH, ionic strength, temperature, co-factors, housekeeping proteins 
and small molecular elements.  
Cysteine proteases utilize a catalytic cysteine residue in the form of a thiolate as 
a nucleophile in proteolytic reactions; therefore, at least in vitro, they require 
reducing agents for their activity [70]. Co-factors are also indispensable for the 
activity of metalloproteases. Zinc is required for aureolysin catalytic activity, but 
it can be substituted with cobalt, producing a protease that is more active than 
the native enzyme [42]. However, the structural stability of the protease is 
maintained by calcium ions. Conformational changes in the tertiary structure of 
the Ca2+-depleted metalloprotease have been confirmed [71]. This not only leads 
to the enzyme’s inactivation, but also makes it susceptible to degradation by 
other proteases [72]. 
The bacterial proteolytic system Clp has analogous structure and function to the 
26S subunit of the eukaryotic proteasome. The Clp complex consists of  
a proteolytic core (ClpP) flanked by Clp ATPases (ClpA or ClpX) (for review 
see: [73]). When ClpP is not associated with Clp ATPase, it is able to degrade 
only small peptides. The whole complex is responsible for specific proteolysis of 
protein substrates, where subunits with ATPase activity play an important role in 
the unfolding and transport of proteins to the proteolytic chamber of ClpP [74]. 
Recent reports have confirmed the importance of Clps in thermal, osmotic and 
pH tolerance, as well as in the virulence of pathogenic bacteria, including  
S. aureus [75-77]. Furthermore, it was shown that acyldepsipeptides isolated 
from the culture medium of Streptomyces hawaiiensis cause non-specific 
activation of ClpP, which leads to uncontrolled degradation of bacterial proteins. 
Moreover, synthetic derivatives of acyldepsipeptides were successfully used as 
antibiotics against dangerous human pathogens, especially methicillin-resistant 
strains of S. aureus [78]. 
The widely conserved heat shock protein DegP is a part of a large family of 
ATP-independent serine proteases, the members of which are found in most 
organisms. They are typically localized in extracytoplasmic compartments such 
as the periplasma of Gram-negative bacteria. The DegP of E. coli has both 
chaperone and protease activities, which are switched in a temperature-
dependent manner [79]. The protease activity is most apparent at higher 
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temperatures. In the chaperone conformation, the protease domain of DegP 
exists in an inactive form [80]. 
 
Acknowledgements. A part of the information included in this review was 
presented during the XXXIV Winter School of the Faculty of Biochemistry, 
Biophysics and Biotechnology of the Jagiellonian University “Cell and its 
environment”, 7-11.03.2007, Zakopane, Poland. This work was partially 
supported by grants 2PO4A00127 and 2PO4A02430 from the Ministry of 
Science and Higher Education (MNiSzW), Poland. The authors would like to 
express their gratitude to Adam and Grzegorz Dubin from the Faculty of 
Biochemistry, Biophysics and Biotechnology for their critical reading of the 
manuscript and important comments.    
 
REFERENCES 
 
1. Potempa, J. and Pike, R.N. Bacterial peptidases. In: Concepts in Bacterial 
Virulence (Russell, W., Herwald, H. Eds.) Contrib Microbiol. Basel, 
Karger, 12 (2005) 132-180. 
2. Yamaguchi, T., Hayashi, T., Takami, H., Nakasone, K., Ohnishi, M., 
Nakayama, K., Yamada, S., Komatsuzawa, H. and Sugai, M. Phage 
conversion of exfoliative toxin A production in Staphylococcus aureus. Mol. 
Microbiol. 38 (2000) 694-705. 
3. Yamaguchi, T., Hayashi, T., Takami, H., Ohnishi, M., Murata, T., 
Nakayama, K., Asakawa, K., Ohara, M., Komatsuzawa, H. and Sugai, M. 
Complete nucleotide sequence of a Staphylococcus aureus exfoliative toxin 
B plasmid and identification of a novel ADP-ribosyltransferase, EDIN-C. 
Infect. Immun. 69 (2001) 7760-7771. 
4. Rice, K., Peralta, R., Bast, D., De Azavedo, J. and McGavin, M.J. 
Description of staphylococcus serine protease (ssp) operon in 
Staphylococcus aureus and nonpolar inactivation of sspA-encoded serine 
protease. Infect. Immun. 69 (2001) 159-169. 
5. Massimi, I., Park, E., Rice, K., Muller-Esterl, W., Sauder, D. and McGavin, 
M.J. Identification of a novel maturation mechanism and restricted substrate 
specificity for the SspB cysteine protease of Staphylococcus aureus. J. Biol. 
Chem. 277 (2002) 41770-41777. 
6. Rzychon, M., Sabat, A., Kosowska, K., Potempa, J. and Dubin, A. 
Staphostatins: an expanding new group of proteinase inhibitors with  
a unique specificity for the regulation of staphopains, Staphylococcus spp. 
cysteine proteinases. Mol. Microbiol. 49 (2003) 1051-1066. 
7. Dubin, G., Krajewski, M., Popowicz, G., Stec-Niemczyk, J., Bochtler, M., 
Potempa, J., Dubin, A. and Holak, T.A. A novel class of cysteine protease 
inhibitors: solution structure of staphostatin A from Staphylococcus aureus. 
Biochemistry 42 (2003) 13449-13456.  
Unauthenticated
Download Date | 5/13/19 11:02 AM
Vol. 13. No. 2. 2008         CELL. MOL. BIOL. LETT.         
 
224 
8. Shaw, L., Golonka, E., Potempa, J. and Foster, S.J. The role and regulation 
of the extracellular proteases of Staphylococcus aureus. Microbiology 150 
(2004) 217-228. 
9. Takeuchi, S., Kinoshita, T., Kaidoh, T. and Hashizume, N. Purification and 
characterization of protease produced by Staphylococcus aureus isolated 
from a diseased chcken. Vet. Microbiol. 67 (1999) 195-202.  
10. Takeuchi, S., Matsunaga, K., Inubushi, S., Higuchi, H., Imaizumi, K. and 
Kaidoh, T. Structural gene and strain specificity of a novel cysteine protease 
produced by Staphylococcus aureus isolated from a diseased chicken. Vet. 
Microbiol. 89 (2002) 201-210. 
11. Dubin, G., Wladyka, B., Stec-Niemczyk, J., Chmiel, D., Zdzalik, M., Dubin, 
A. and Potempa, J. The staphostatin family of cysteine protease inhibitors in 
Staphylococcus genus as an example of parallel evolution of protease and 
inhibitor specificity. Biol. Chem. 388 (2007) 227-235. 
12. Dubin, G., Stec-Niemczyk, J., Dylag, T., Silbering, J., Dubin, A. and 
Potempa, J. Characterisation of a highly specific, endogenous inhibitor of 
cysteine protease from Staphylococcus epidermidis, a new member of the 
staphostatin family. Biol. Chem. 385 (2004) 543-546. 
13. Potempa, J., Golonka, E., Filipek, R. and Shaw, L.N. Fighting an enemy 
within: cytoplasmic inhibitors of bacterial cysteine proteases. Mol. 
Microbiol. 57 (2005) 605-610. 
14. Reed, S.B., Wesson, C.A., Liou, L.E., Trumble, W.R., Schlievert, P.M., 
Bohach, G.A. and Bayles, K.W. Molecular characterization of a novel 
Staphylococcus aureus serine protease operon. Infect. Immun. 69 (2001) 
1521-1527. 
15. Duong, F., Lazdunski, A., Cami, B. and Murgier, M. Sequence of a cluster 
of genes controlling synthesis and secretion of alkaline proteinase in 
Pseudomonas aeruginosa: relationships to other secretory pathways. Gene 
121 (1992) 47-54. 
16. Kagawa, T.F., O’Toole, P.W. and Cooney, J.C. SpeB-Spi: a novel protease-
inhibitor pair from Streptococcus pyogenes. Mol. Microbiol. 57 (2005) 650-
666. 
17. Rzychon, M., Filipek, R., Sabat, A., Kosowska, K., Potempa, J., Dubin, A. 
and Bochtler, M. Staphostatins resemble lipocalins, not cystatins in fold. 
Protein Sci. 12 (2003) 2252-2256. 
18. Recsei, P., Kreiswirth, B., O’Reilly, M., Schlievert, P., Gruss, A. and 
Novick, R.P. Regulation of exoprotein gene expression in Staphylococcus 
aureus by agr. Mol. Gen. Genet. 202 (1986) 58-61. 
19. Bayer, M.G., Heinrichs, J.H. and Cheung, A.L. The molecular architecture 
of the sar locus in Staphylococcus aureus. J. Bacteriol. 178 (1996) 4563-
4570. 
20. Novick, R.P., Projan, S.J., Kornblum, J., Ross, H.F., Ji, G., Kreiswirth, 
B.,Vandenesch, F. and Moghazeh, S. The agr P2 operon: an autocatalytic 
Unauthenticated
Download Date | 5/13/19 11:02 AM
CELLULAR & MOLECULAR BIOLOGY LETTERS 
 
225 
 
sensory transduction system in Staphylococcus aureus. Mol. Gen. Genet. 
248 (1995) 446-458. 
21. Ji, G., Beavis, R.C. and Novick, R.P. Cell density control of staphylococcal 
virulence mediated by an octapeptide pheromone. Proc. Natl. Acad. Sci. 
USA 92 (1995) 12055-12059.  
22. Gambello, M.J., Kaye, S. and Iglewski, B.H. LasR of Pseudomonas 
aeruginosa is a transcriptional activator of the alkaline protease gene (apr) 
and an enhancer of exotoxin A expression. Infect. Immun. 61 (1993) 1180-
1184. 
23. Passador, L., Cook, J.M., Gambello, M.J., Rust, L. and Iglewski, B.H. 
Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell 
communication. Science 260 (1993) 1127-1130. 
24. Heinrichs, J.H., Bayer, M.G. and Cheung, A.L. Characterization of the sar 
locus and its interactions with agr in Staphylococcus aureus. J. Bacteriol. 
178 (1996) 418-423. 
25. Cheung, A.L., Bayer, M.G. and Heinrichs, J.H. sar genetic determinants 
necessary for transcription of RNAII and RNAIII in the agr locus of 
Staphylococcus aureus. J. Bacteriol. 179 (1997) 3963-3971. 
26. Chien, Y., Manna, A.C., Projan, S.J. and Cheung, A.L. SarA, a global 
regulator of virulence determinants in Staphylococcus aureus, binds to a 
conserved motif essential for sar-dependent gene regulation. J. Biol. Chem. 
274 (1999) 37169-37176. 
27. Chan, P.F. and Foster, S.J. Role of SarA in virulence determinant production 
and environmental signal transduction in Staphylococcus aureus.  
J. Bacteriol. 180 (1998) 6232-6241. 
28. McNamara, P.J., Milligan-Monroe, K.C., Khalili, S. and Proctor, R.A. 
Identification, cloning, and initial characterization of rot, a locus encoding  
a regulator of virulence factor expression in Staphylococcus aureus.  
J. Bacteriol. 182 (2000) 3197-3203. 
29. Saïd-Salim, B., Dunman, P.M., McAleese, F.M., Macapagal, D., Murphy, 
E., McNamara, P.J., Arvidson, S., Foster, T.J., Projan, S.J. and Kreiswirth, 
B.N. Global regulation of Staphylococcus aureus genes by Rot. J. Bacteriol. 
185 (2003) 610-619. 
30. Horsburgh, M., Aish, J., White, I., Shaw, L., Lithgow, J. and Foster, S. 
SigmaB modulates virulence determinant expression and stress resistance: 
characterization of a functional rsbU strain derived from Staphylococcus 
aureus 8325-4. J. Bacteriol. 184 (2002) 5457-5467. 
31. Shaw, L.N., Golonka, E., Szmyd, G., Foster, S.J., Travis, J. and Potempa, J. 
Cytoplasmic control of premature activation of a secreted protease zymogen: 
deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a 
profound pleiotropic phenotype. J. Bacteriol. 187 (2005) 1751-1762. 
32. Lowther, W.T. and Matthews, B.W. Structure and function of the methionine 
aminopeptidases. Biochim. Biophys. Acta 1477 (2000) 157-167. 
Unauthenticated
Download Date | 5/13/19 11:02 AM
Vol. 13. No. 2. 2008         CELL. MOL. BIOL. LETT.         
 
226 
33. Tuteja, R. Type I signal peptidase: an overview. Arch. Biochem. Biophys. 
441 (2005) 107-111. 
34. Neurath, H. The versatility of proteolytic enzymes. J. Cell Biochem. 32 
(1986) 35-49. 
35. Vasantha, N., Thompson, L.D., Rhodes, C., Banner, C., Nagle, J. and 
Filpula, D. Genes for alkaline protease and neutral protease from Bacillus 
amyloliquefaciens contain a large open reading frame between the regions 
coding for signal sequence and mature protein. J. Bacteriol. 159 (1984) 
811-819. 
36. Zhu, X., Ohta, Y., Jordan, F. and Inouye, M. Pro-sequence of subtilisin can 
guide the refolding of denatured subtilisin in an intermolecular process. 
Nature 339 (1989) 483-484. 
37. Sabat, A., Kosowska, K., Poulsen, K., Kasprowicz, A., Sekowska, A., van 
der Burg, B., Travis, J. and Potempa, J. Two allelic forms of the aureolysin 
gene (aur) within Staphylococcus aureus. Infect. Immun. 68 (2000) 973-976. 
38. Miyoshi, S. and Shinoda, S. Microbal metalloproteases and pathogenesis. 
Microbes Infect. 2 (2000) 91-98. 
39. Carmona, C. and Gray, G.L. Nucleotide sequence of the serine protease gene 
of Staphylococcus aureus, strain V8. Nucleic Acids Res. 15 (1987) 6757. 
40. Yoshikawa, K., Tsuzuki, H., Fujiwara, T., Nakamura, E., Iwamoto, H., 
Matsumoto, K., Shin, M., Yoshida, N. and Teraoka, H. Purification, 
characterization and gene cloning of a novel glutamic acid-specific 
endopeptidase from Staphylococcus aureus ATCC 12600. Biochim. 
Biophys. Acta 1121 (1992) 221-228. 
41. Beaudet, R., Saheb, S.A. and Drapeau, G.R. Structural heterogenicity of the 
protease isolated from several strains of Staphylococcus aureus. J. Biol. 
Chem. 249 (1974) 6468-6471. 
42. Drapeau, G.R. Role of a metalloprotease in activation of the precursor of 
staphylococcal protease. J. Bacteriol. 136 (1978) 607-613. 
43. Lindsay, J. and Foster, S. Interactive regulatory pathways control virulence 
determinant production and stability in response to the environment in 
Staphylococcus aureus. Mol. Gen. Genet. 262 (1999) 323-331. 
44. Filipek, R., Szczepanowski, R., Sabat, A., Potempa, J. and Bochtler, M. 
Prostaphopain B structure: a comparison of proregion-mediated and 
staphostatin-mediated protease inhibition. Biochemistry 43 (2004) 14306-
14315. 
45. Popowicz, G.M., Dubin, G., Stec-Niemczyk, J., Czarny, A., Dubin, A., 
Potempa, J. and Holak, T.A. Functional and structural characterization of 
Spl proteases from Staphylococcus aureus. J. Mol. Biol. 358 (2006) 270-279. 
46. Rasmussen, M. and Björck, L. Proteolysis and its regulation at the surface of 
Streptococcus pyogenes. Mol. Microbiol. 43 (2002) 537-544. 
47. Kagawa, T.F., Cooney, J.C., Baker, H.M., McSweeney, S., Liu, M., Gubba, 
S., Musser, J.M. and Baker, E.N. Crystal structure of the zymogen form of 
Unauthenticated
Download Date | 5/13/19 11:02 AM
CELLULAR & MOLECULAR BIOLOGY LETTERS 
 
227 
 
the group A Streptococcus virulence factor SpeB: an integrin-binding 
cysteine protease. Proc. Natl. Acad. Sci. USA 97 (2000) 2235-2240. 
48. Doran, J.D., Nomizu, M., Takebe, S., Ménard, R., Griffith, D. and Ziomek, 
E. Autocatalytic processing of the streptococcal cysteine protease zymogen: 
processing mechanism and characterization of the autoproteolytic cleavage 
sites. Eur. J. Biochem. 263 (1999) 145-151. 
49. Braun, P., de Groot, A., Bitter W. and Tommassen, J. Secretion of 
elastolytic enzymes and their propeptides by Pseudomonas aeruginosa.  
J. Bacteriol. 173 (1998) 3467-3469. 
50. Miyoshi, S., Wakae, H., Tomochika, K. and Shinoda, S. Functional domains 
of a zinc metalloprotease from Vibrio vulnificus. Infect. Immun. 179 (1997) 
7606-7609. 
51. Prokesová, L., Porwit-Bobr, Z., Baran, K., Potempa, J., Pospisil, M. and 
John, C. Effect of metalloproteinase from Staphylococcus aureus on in vitro 
stimulation of human lymphocytes. Immun. Lett. 27 (1991) 225-230. 
52. Potempa, J., Watorek, W. and Travis, J. The inactivation of human plasma 
α1-proteinase inhibitor by proteinases form Staphylococcus aureus. J. Biol. 
Chem. 261 (1986) 14330-14334. 
53. Potempa, J., Fedak, D., Dubin, A., Mast, A. and Travis, J. Proteolytic 
inactivation of α-1-antichymotrypsin. Sites of cleavage and generation of 
chemotactic activity. J. Biol. Chem. 266 (1991) 21482-21487. 
54. Amagai, M., Matsuyoshi, N., Wang, Z.H., Andl, C. and Stanley, J.R. Toxin 
in bullous impetigo and staphylococcal scalded-skin syndrome targets 
desmoglein 1. Nature Med. 6 (2000) 1275-1277. 
55. Arvidson, S. Extracellular enzymes. In: Gram-Positive Pathogens 
(Fischetti, V.A., Novick, R.P., Ferretti, J.J., Portnoy, D.A. and Rood, J.I. 
Eds.) Washington, D.C., USA, American Society for Microbiology, pp. 379-
385. 
56. Potempa, J., Dubin, A., Korzus, G. and Travis, J. Degradation of elastin by  
a cysteine proteinase from Staphylococcus aureus. J. Biol. Chem. 263 
(1988) 2664-2667. 
57. Imamura, T., Tanase, S., Szmyd, G., Kozik, A., Travis, J. and Potempa, J. 
Induction of vascular leakage through release of bradykinin and a novel 
kinin by cysteine proteinases from Staphylococcus aureus. J. Exp. Med. 
201 (2005) 1669-1676. 
58. Rieneck, K., Rennenberg, J., Diamant, M., Gutschik, E. and Bendtzen, K. 
Molecular cloning and expression of novel Staphylococcus aureus antigen. 
Biochim. Biophys. Acta 44 (1997) 128-132. 
59. Matsumoto, K. Role of bacterial proteases in pseudomonal and serratial 
keratitis. Biol. Chem. 385 (2004) 1007-1016. 
60. Dubin, G., Popowicz, G., Krajewski, M., Potempa, J., Dubin, A. and Holak, 
T.A. 1H, 15N and 13C NMR resonance assignments of staphostatin A,  
a specific Staphylococcus aureus cysteine proteinase inhibitor. J. Biomol. 
NMR 28 (2004) 295-296. 
Unauthenticated
Download Date | 5/13/19 11:02 AM
Vol. 13. No. 2. 2008         CELL. MOL. BIOL. LETT.         
 
228 
 
 
61. Filipek, R., Rzychon, M., Oleksy, A., Gruca, M., Dubin, A., Potempa, J. and 
Bochtler, M. The staphostatin-staphopain complex: a forward binding 
inhibitor in complex with its target cysteine protease. J. Biol. Chem. 278 
(2003) 40959-40966. 
62. Dubin, G. Defense against own arms: staphylococcal cysteine proteases and 
their inhibitors. Acta Biochim. Polon. 50 (2003) 715-724. 
63. Wladyka, B., Puzia, K. and Dubin, A. Efficient co-expression of  
a recombinant staphopain A and its inhibitor staphostatin A in Escherichia 
coli. Biochem. J. 385 (2005) 181-187. 
64. Herwald, H., Collin, M., Muller-Esterl, W. and Björck, L. Streptococcal 
cysteine proteinase releases kinins: a virulence mechanism. J. Exp. Med. 
184 (1996) 665-673. 
65. Schroeter, J.P., Kolodziej, S.J., Wagenknecht, T., Bretaudiere, J.P., Tapon-
Bretaudiere, J., Strickland, D.K. and Stoops, J.K. Three-dimensional 
structures of the human alpha 2-macroglobulin-methylamine and 
chymotrypsin complexes. J. Struct. Biol. 109 (1992) 235-247.  
66. Starkey, P.M. and Barrett, A.J. Inhibition by α-macroglobulin and other 
serum proteins. Biochem. J. 131 (1973) 823-831. 
67. Sottrup-Jensen, L., Sand, O., Kristensen, L. and Fey, G.H. The  
α-macroglobulin bait region. Sequence diversity and localization of cleavage 
sites for proteinases in five mammalian α-macroglobulins. J. Biol. Chem. 
264 (1989) 15781-15789. 
68. Maeda, S., Molla, T., Oda, A. and Katsuki, T. Internalization of serratia1 
protease into cells as an enzyme-inhibitor complex with α2-macroglobulin 
and regeneration of protease activity and cytotoxicity. J. Biol. Chem. 262 
(1987) 10946-10950. 
69. Nyberg, P., Rasmussen, M. and Björck, L. α2-macroglobulin-proteinase 
complexes protect Streptococcus pyogenes from killing by the antimicrobal 
peptide LL-37. J. Biol. Chem. 279 (2004) 52820-52823. 
70. Giles, N.M., Watts, A.B., Giles, G.I., Fry, F.H., Littlechild, J.A. and Jacob, 
C. Metal and redox modulation of cysteine protein function. Chem. Biol. 10 
(200) 3677-1093. 
71. Wasylewski, Z., Stryjewski, W., Wasniowska, A., Potempa, J. and Baran, K. 
Effect of calcium binding on conformational changes of staphylococcal 
metalloproteinase measured by means of intrinsic protein fluorescence. 
Biochim. Biophys. Acta 871 (1986) 177-181. 
72. Potempa, J., Porwit-Bobr, Z. and Travis, J. Stabilization vs. degradation of 
Staphylococcus aureus metalloproteinase. Biochim. Biophys. Acta 993 
(1989) 301-304. 
73. Gottesman, S. Regulation by proteolysis: developmental switches. Curr. 
Opin. Microbiol. 2 (1999) 142-147. 
Unauthenticated
Download Date | 5/13/19 11:02 AM
CELLULAR & MOLECULAR BIOLOGY LETTERS 
 
229 
 
74. Hoskins, J.R., Singh, A.K., Maurizi, M.R. and Wickner, S. Protein binding 
and unfolding by the chaperone ClpA and degradation by the protease 
ClpAP. Proc. Natl. Acad. Sci. USA 97 (2000) 8892-8897. 
75. Frees, D., Qazi, S.N., Hill, P.J. and Ingmer, H. Alternative roles of ClpX and 
ClpP in Staphylococcus aureus stress tolerance and virulence. Mol. 
Microbiol. 48 (2003) 1565-1578. 
76. Frees, D., Sørensen, K. and Ingmer, H. Global virulence regulation in 
Staphylococcus aureus: pinpointing the roles of ClpP and ClpX in the 
sar/agr regulatory network. Infect. Immun. 73 (2005) 8100-8108. 
77. Butler, S.M., Festa, R.A., Pearce, M.J. and Darwin, K.H. Self-
compartmentalized bacterial proteases and pathogenesis. Mol. Microbiol. 
60 (2006) 553-562. 
78. Brötz-Oesterhelt, H., Beyer, D., Kroll, H.P., Endermann, R., Ladel, C., 
Schroeder, W., Hinzen, B., Raddatz, S., Paulsen, H., Henninger, K., 
Bandow, J.E., Sahl, H.G. and Labischinski, H. Disregulation of bacterial 
proteolytic machinery by a new class of antibiotics. Nat. Med. 11 (2005) 
1082-1087. 
79. Spiess, C., Beil, A. and Ehrmann, M. A temperature-dependent switch from 
chaperon to protease in widely conserved heat shock protein. Cell 97 (1999) 
339-347. 
80. Clausen, T., Southan, C. and Ehrmann, M. The HrtA family of proteases: 
implications for protein coposition and cell fate. Mol. Cell 10 (2002) 443-455. 
 
 
 
 
 
 
 
  
 
 
 
 
 
Unauthenticated
Download Date | 5/13/19 11:02 AM
